KRAS and cancer stem cells in APC-mutant colorectal cancer.
Affiliations of authors: Department of Internal Medicine (ERF, MSW), Department of Human Genetics (ERF), Department of Pathology (ERF), and the Cancer Center (ERF, MSW), University of Michigan Medical School, Ann Arbor, MI.
Eric R
ER
Fearon
Max S
MS
Wicha
D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000378:metabolism*; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation; D014411:Neoplastic Stem Cells / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D051153:Wnt Proteins / Q000378:metabolism*; D051176:beta Catenin / Q000378:metabolism*; D018631:ras Proteins / Q000235:genetics*
C495270:CTNNB1 protein, human; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D051153:Wnt Proteins; D051176:beta Catenin; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins